Stay updated on PD-1 and NK Immunotherapy Combo in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the PD-1 and NK Immunotherapy Combo in Solid Tumors Clinical Trial page.

Latest updates to the PD-1 and NK Immunotherapy Combo in Solid Tumors Clinical Trial page
- Check2 days agoChange DetectedThe only change is the revision label updated from v3.3.3 to v3.3.4; no substantive edits to the Study Details page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedAdded a Locations section showing Guangdong as a study site and updated the footer to Revision: v3.3.3; the prior Guangdong Locations and HHS Vulnerability Disclosure were removed.SummaryDifference0.3%

- Check52 days agoChange DetectedPublications section updated to clarify that entries are automatically filled from PubMed and may not be about the study, and the revision tag was updated to v3.3.2; the deletion note reiterates PubMed as the source with revision tag v3.2.0.SummaryDifference0.1%

- Check59 days agoChange DetectedRemoved the government funding lapse notice from the page, including references to NIH Clinical Center operating status and opm.gov updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check74 days agoChange DetectedThe new screenshot appears to show only UI and layout updates (header, spacing, font) without changes to core trial details such as enrollment, locations, eligibility, or outcome measures. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check102 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference5%

Stay in the know with updates to PD-1 and NK Immunotherapy Combo in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD-1 and NK Immunotherapy Combo in Solid Tumors Clinical Trial page.